Evaluating commercial sensors for clinical gait analysis
Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis in Adult Patients With Neurological Disorders
This study tests if commercial sensors can effectively measure walking patterns in adults with neurological disorders compared to standard clinical methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Roessingh Research and Development Academic / other |
| Locations | 1 site (Enschede) |
| Trial ID | NCT05751408 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the usability of commercial Inertial Measurement Units (IMUs) for clinical gait analysis in adult patients with neurological disorders. Participants will undergo routine clinical 3D gait analysis using Vicon technology, while also incorporating IMU sensors to collect data on acceleration, gyroscope, and magnetometer readings from various body parts. The goal is to compare the performance of these commercial sensors against standard clinical methods, focusing on patients with conditions affecting their walking ability.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with neurological disorders that affect walking, such as stroke, traumatic brain injury, or multiple sclerosis.
Not a fit: Patients referred for gait analysis due to issues unrelated to stiff knee gait or foot surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy and efficiency of gait analysis in clinical settings, leading to better treatment plans for patients with neurological disorders.
How similar studies have performed: While the use of IMUs in sports and healthy individuals has been explored, this specific application in clinical gait analysis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Subjects referred for clinical gait analysis at Roessingh Centre for Rehabilition in Enschede, the Netherlands: Inclusion Criteria: * Disorders affecting walking, including amongst others stroke, traumatic brain injury, MS, incomplete spinal cord injury, CP, Spina Bifida, neuromuscular diseases * age minimum 18 years * Viosca score minimum 2; meaning minimal independent walking ability indoors * increased fall risk or increased effort of walking because of: 1) decreased stability during stance; and/or 2) decreased foot clearance during swing; and/or 3) not able to walk on bare feet because of equinovarus; and/or 4) fatigue during walking because of compansatory strategies. Exclusion Criteria: * subjects referred for clinical gait analysis because of problems other than stiff knee gait or foot surgery * severe deficits in communication, memory and understanding at such a level that it would affect instructions during the measurements
Where this trial is running
Enschede
- Roessingh Research and Development — Enschede, Netherlands (Recruiting)
Study contacts
- Principal investigator: C Nikamp, PhD — Roessingh Research and Development
- Study coordinator: C Nikamp, PhD
- Email: c.nikamp@rrd.nl
- Phone: +31880875777
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.